DWM
SQZ

Dakota Wealth Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Dakota Wealth Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,000
Closed -$46K – 658
2022
Q3 		$46K Hold
20,000
– – ﹤0.01% 568
2022
Q2 		$64K Buy
+20,000
New +$72K 0.01% 505

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Dakota Wealth Management's SQZ Position: Q4 2022 in Review

Dakota Wealth Management sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 20,000 shares — an estimated $46K sold.

Dakota Wealth Management first reported a position in SQZ in Q2 2022 and held it in 2 quarters. The position peaked at $64K in Q2 2022. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

  • Dakota Wealth Management reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
  • Dakota Wealth Management sold 20,000 SQZ Biotechnologies Company shares in Q4 2022, an estimated $46K.
  • Dakota Wealth Management first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 2 quarters.
  • Dakota Wealth Management's SQZ Biotechnologies Company position peaked at $64K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on Dakota Wealth Management's 13F filing for Q4 2022, filed 8 Feb 2023.